These lab-created solutions were not developed with recreational use in mind. During the nineties, John W. Huffman as well as a workforce of fellow chemists at Clemson College made a number of the very first formulation for artificial cannabinoid receptor agonists (SCRAs), a loved ones of substances that imitate the physiological and psychological